Positive imaging of cardiomyopathy with99mTc(V)-DMSA

descriptionPublicationkeyboard_double_arrow_right Article 01 Dec 1992 English Publisher:Springer Science and Business Media LLCJournal:Annals of Nuclear Medicine, volume 6, pages 269-271 (issn: 0914-7187, eissn: 1864-6433,

Copyright policy )

Authors: H, Ohta; T, Komibuchi; S, Kawamata; K, Yamamoto; M, Shichirousako; T, Wada; H, Kotoura; +3 Authors

doi: 10.1007/bf03164665

pmid: 1336965

Positive imaging of cardiomyopathy with99mTc(V)-DMSA

- Summary
- Subjects
- Metrics

Abstract

A case of histologically proven dilated cardiomyopathy and a case of clinically diagnosed cardiomyopathy (cardiac amyloidosis was strongly suspected but was not confirmed) were examined with 99mTc(V)-dimercaptosuccinic acid (DMSA). 99mTc(V)-DMSA accumulation in the damaged myocardium was clearly demonstrated. These results suggested the possibility that 99mTc(V)-DMSA could be used as a positive agent for cardiomyopathy.

Related Organizations

Keywords

Cardiomyopathy, Dilated, Male, Tomography, Emission-Computed, Single-Photon, Organotechnetium Compounds, Middle Aged, Technetium Tc 99m Dimercaptosuccinic Acid, Humans, Female, Cardiomyopathies, Succimer, Aged

Impact byBIP!

	citations The total number of citations received by all articles of the researcher of interest.	2
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average